Cambridge Investment Research Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-23,098	Closed	-$404K	–	1837
2016 Q3	$404K	Buy	+23,098	New	+$383K	0.01%	1151
2016 Q2	–	Sell	-23,093	Closed	-$455K	–	1694
2016 Q1	$455K	Buy	23,093 +940	+4%	+$15.1K	0.01%	952
2015 Q4	$421K	Buy	+22,153	New	+$452K	0.01%	936
2015 Q3	–	Sell	-17,560	Closed	-$815K	–	1611
2015 Q2	$815K	Sell	17,560 -9,700	-36%	-$421K	0.02%	587
2015 Q1	$1.19M	Buy	27,260 +448	+2%	+$20.8K	0.03%	447
2014 Q4	$930K	Hold	26,812	–	–	0.03%	514
2014 Q3	$1.12M	Buy	26,812 +20,085	+299%	+$897K	0.03%	477
2014 Q2	$394K	Hold	6,727	–	–	0.01%	870
2014 Q1	$424K	Buy	6,727 +100	+2%	+$6.63K	0.02%	798
2013 Q4	$388K	Buy	6,627 +110	+2%	+$5.75K	0.02%	760
2013 Q3	$343K	Buy	6,517 +100	+2%	+$6.71K	0.02%	780
2013 Q2	$494K	Buy	+6,417	New	+$524K	0.03%	556

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Cambridge Investment Research Advisors's ARNA Position: Q4 2016 in Review

Cambridge Investment Research Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2016, closing a stake of 23,098 shares — an estimated $404K sold.

Cambridge Investment Research Advisors first reported a position in ARNA in Q2 2013 and held it in 12 quarters. The position peaked at $1.19M in Q1 2015. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

Cambridge Investment Research Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Cambridge Investment Research Advisors sold 23,098 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $404K.
Cambridge Investment Research Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
Cambridge Investment Research Advisors's Arena Pharmaceuticals Inc position peaked at $1.19M in Q1 2015.
128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.